# A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms

> **NCT05264350** · NA · COMPLETED · sponsor: **Viiral Nordic AB** · enrollment: 84 (actual)

## Conditions studied

- Rhinitis Sicca

## Interventions

- **DEVICE:** Sialic acid nasal spray
- **DEVICE:** Isotonic Saline Nasal Spray

## Key facts

- **NCT ID:** NCT05264350
- **Lead sponsor:** Viiral Nordic AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-03
- **Primary completion:** 2022-08-16
- **Final completion:** 2022-09-15
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264350, "A Post-Market Clinical Follow-up Investigation to Verify Performance and Safety of Viiral®Nasal Spray in Subjects With Dry Nose Symptoms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05264350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*